Now enrolling for a phase 3 clinical trial of an investigational medication for atopic dermatitis, also known as eczema.
Study participants must be at least 12 years of age or older. This study will compare injections of nemolizumab (CD14152) to placebo (placebo looks like the study medication but contains no active drug). All study-related care and study medication will be provided at no charge. Reimbursement for time and participation available.
Visit www.arcadiastudy.com for more information or contact Ektor Rafti, M.D., @ erafti@uchc.edu or Meg Toro @ mtoro@uchc.edu
Principal Investigator: Jun Lu, M.D.
UConn Health IRB # W20-195-1
For more information, contact: Meg Toro at mtoro@uchc.edu